AUTOIMMUNE HAEMOLYTIC ANAEMIA
Clinical trials for AUTOIMMUNE HAEMOLYTIC ANAEMIA explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HAEMOLYTIC ANAEMIA trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HAEMOLYTIC ANAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BIVV020 tested for rare blood disorder
Disease control CompletedThis early-stage trial tested a single dose of the drug BIVV020 in 12 adults with cold agglutinin disease, a rare condition where the immune system mistakenly attacks red blood cells. The main goal was to see if the drug is safe and tolerable. Researchers also looked at how it af…
Matched conditions: AUTOIMMUNE HAEMOLYTIC ANAEMIA
Phase: PHASE1 • Sponsor: Bioverativ, a Sanofi company • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New study aims to unlock the secrets of Children's rare blood diseases
Knowledge-focused CompletedThis study follows children in France diagnosed with severe autoimmune cytopenia—conditions where the immune system attacks blood cells. Researchers will track their health over time to see who achieves remission and what factors influence their recovery. The goal is to better un…
Matched conditions: AUTOIMMUNE HAEMOLYTIC ANAEMIA
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC